Sanrai International

Mobile Health Technology Company Dedicated to Transforming P...


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

Sanrai International is a sales and services company with a seasoned, U.S.-led Management team who is focused on bringing innovative products to market internationally.  We’re a thought leader in the home healthcare space in India, and we are expanding our influence with technological advances that allow patients anywhere to have access to digital and mobile health innovations directly from countries that discover them. Sanrai group, our parent company specializes in respiratory oxygen therapies associated with chronic obstructive pulmonary disease (COPD) and has recently expanded its portfolio to include integrations to address sleep disorders and other telemedicine applications.

In Telemedicine, one of our superstar products is Dyna-Vision™, an innovative remote patient monitoring device that improves the lives of sufferers of chronic illnesses (including cardiac disease and pulmonary disorders).  Sanrai has distribution rights to this product in India. 

We also offer the full spectrum of business capabilities from product development and regulatory support to marketing and distribution enablement.  We have a complete suite of services to captivate and connect our customers – physicians, manufacturers, entrepreneurs and patients - to a global audience, empowering them to focus on what matters most – saving lives.

We’ve got big plans for patient care, and will continue to build our business until we reach as many of your loved ones as we possibly can.

If you aren’t innovating, you aren’t important.  This reality is faced by many in today’s ultra-competitive, tech-crazed business world.

While companies in all industries are spending big bucks to improve their technology and keep up, outside forces are holding them down.  This is especially true for wireless technologies.  Companies are constantly developing cutting-edge wireless products only to see them not being used to their full potential due to inefficient wireless infrastructure in the world around them.

At Sanrai, we’re a known thought leader in the respiratory and sleep home care space.  With our latest market introduction, the Dyna-Vision™ patient monitor, we’re mastering the art of patient care during life's difficult transitions – allowing assisted living facilities to save on space while medical staff can simultaneously save the maximum number of lives.

This device, for example, offers numerous measurable advantages for home care facilities, including:

Improved patient care and satisfaction scores

Enhanced staff performance, productivity and morale

Reduced chronic alarm fatigue

Increased patient and staff security

Support for HIPAA privacy-compliance efforts

Reduced hospital re-admissions

Dyna-Vision’s™ remote monitoring capabilities may be what set it apart, but there’s so much more value to be had.  It offers a stable and robust info capture infrastructure, collecting critical medical data and delivering life-saving analytics in a matter of seconds.  In addition, it tracks important vitals and quickly transmits medical parameters throughout health care professionals, making it ideal for those suffering from chronic disease.  When it’s all said and done, Dyna-Vision™ features several unique applications specially designed to improve the lives of those in your care. Here’s some of what makes us the most proud:

  • It’s Wi-Fi and 3G enabled to send to and receive data in real time.
  • Installable on multiple workstations, the software allows for the monitoring of 64 patients on a single screen.
  • It’s designed for use with a variety of monitoring applications like cardiac events, vital signs, sleep apnea, 12-lead resting ECG, EMS monitoring, and drug studies.
  • The software also calculates the beat-to-beat blood pressure and respiration rate for the patient.  The system includes easy reporting tools for alert events, daily statistics, and complete monitoring sessions.
  • It features the collection and transmission of 3, 5, and 12-lead ECG, heart rate, Plethysmogram, Sp02 temperature, and respiration rate.
  • The operator can configure 4 alert levels for each collected parameter.
  • Specially designed modules for cardiology, pulmonology and orthopedic applications

Just in case the ground-breaking innovation that is Dyna-Vision™ hasn’t convinced you yet, here are some more of the impressive things Sanrai International has already accomplished:

  • Solid investor history.  We’ve secured seed funding through private investors.
  • Joint venture with Alliance Telehealth. They were a US-based telemedicine thought leader – and they’re with us now.  We’ll own 51% of the sales distribution profits and will head up their upcoming foray into India, Africa, Middle East, and Americas distribution.
  • Sales Traction.  Our pipeline is building rapidly with accounts in the Respiratory, Digital Health, Telemedicine, and Orthopedics verticals (currently projecting ~$10 million in sales annually). A $5 million per year orthopedics innovation launch is expected to begin in January 2016.
  • Big-name Relationships.  Already-established relationships include industry leaders Philips, ResMed and Chart Industries
  • Special project partners. In-progress studies are underway with Philips and Lifespan, an Indian diabetes home care service.

  

​ For more on our exciting future, please request access to our business plan!

The Sanrai International story began in early 2015 with the founders expanding their business footprint beyond medical home care services in India that began in 2007.

Jaspreet Rai is the Founder and currently the driving force behind Sanrai International. Ms. Rai took Sanrai India from a mere concept in 2007 and built it into an established successful organization. Through strategic mergers and acquisitions, Sanrai India is the only organized durable medical equipment retailer and homecare service provider in the Indian market. She has established 16 offices pan-India and is looking to use her strength in India as a key asset for Sanrai International. 

Mahim Chellappa serves as CFO, Sanrai International at Sanrai Group.  He’s a financial guru who has 8+ years in investment banking at Citi and Credit Suisse, and has run portfolio operations for several U.S. companies.  

Seetha Ramnath is Sanrai Alliance's Chief Marketing Officer.  She’s led marketing, customer relations and operations functions for companies such as Accenture LLP, L’Oreal Paris, Johnson & Johnson and Gallup.  Ms. Ramnath is responsible for branding and in charge of global marketing activities.

James Gilkison is Sanrai International’s Global Director of Sales and has been a top-performing Regional Sales Manager in the domestic and international respiratory homecare arena/biomedical industry for over 20 years.  With a strong technical and clinical background, he specializes in growing international markets and new product development.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service funding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.